CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) (USD $)	Total	Common Stock	Preferred Stock	Additional Paid-in Capital	Common Stock Issuable	Deficit Accumulated During the Development Stage
Beginning Balance at Dec. 31, 2012	$ 17,810,186	$ 12,934		$ 110,116,766		$ (92,319,514)
Beginning Balance (in shares) at Dec. 31, 2012		12,934,350
Proceeds from the sale of preferred stock sold at $25.00 per share and common stock at $2.50 per share, net of offering costs (in shares)		6,670,000	220,000
Proceeds from the sale of preferred stock sold at$25.00 per share and common stock at $2.50 per share, net of offering costs	20,754,418		6,890	20,747,528		0
Proceeds from the sale of common stock at $3.30 per share, net of offering costs (in shares)		1,058,951
Proceeds from the sale of common stock at $3.30 per share, net of offering costs	3,388,095	1,059		3,387,036
Stock-based compensation to employees and directors for the period from January 1, 2013 to September 30, 2013	935,736			935,736		0
Stock-based payments to consultants for the period from January 1, 2013 to June 30, 2013	29,317			29,317
Common stock issuable for compensation (125,000 shares)	368,750				368,750
Stock-based compensation related to the restricted stock grant	117,885			117,885
Net loss for the period	(13,356,725)					(13,356,725)
Ending Balance at Sep. 30, 2013	$ 30,047,662	$ 20,883		$ 135,334,268	$ 368,750	$ (105,676,239)
Ending Balance (in shares) at Sep. 30, 2013		20,663,301	220,000